Tumor necrosis factor α, but not Fas, mediates hepatocellular apoptosis in the murine ischemic liver

Gastroenterology

Volumn 122, Issue 1, 2002, Pages 202-210

  Rüdiger, Hannes A ^a   Clavien, PierreAlain ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; PENTOXIFYLLINE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; KNOCKOUT MOUSE; LIVER CELL; LIVER ISCHEMIA; MALE; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

EID: 0036142543     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2002.30304     Document Type: Article

References (55)

1. Endothelial cell and hepatocyte deaths occur by apoptosis after ischemia-reperfusion injury in the rat liver
2. Apoptosis of sinusoidal endothelial cells is a critical mechanism of prevention injury in rat liver transplantation
3. A caspase inhibitor fully protects rats against lethal normothermic liver ischemia by inhibition of liver apoptosis
4. Mechanisms of hepatic toxicity
5. Death-inducing functions of ligands of the tumor necrosis factor family: A Sanhedrin verdict
6. Lethal effect of the anti-Fas antibody in mice
7. The Fas death factor
8. CD95(APO-1/Fas)-mediated apoptosis: Live and let die
9. The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation and death
10. Cell death induction by receptors of the TNF family: Towards a molecular understanding
11. CD95-induced apoptosis in human liver disease
12. Transducing signals of life and death
13. The production of tumor necrosis factor alpha and the development of a pulmonary capillary injury following hepatic ischemia/reperfusion
14. The role of cytokine networks in the local liver injury following heptic ischemia/reperfusion in the rat
15. Differential effect of anti-TNF-alpha antibody on proinflammatory cytokine release by Kupffer cells following liver ischemia and reperfusion
16. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways
17. Tumor necrosis factor alpha in the pathogenesis of human and murine fulminant hepatic failure
18. The type 1 receptor (CD120a) is the high-affinity receptor for soluble tumor necrosis factor
19. The two different receptors for tumor necrosis factor mediate distinct cellular responses
20. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kB activation prevents cell death
21. Monoclonal antibody-mediated tumor regression by induction of apoptosis
22. Perforin and Fas/Fas ligand-mediated cytotoxicity in acute and chronic woodchuck viral hepatitis
23. Serum levels of soluble Fas antigen in chronic hepatitis C patients
24. CD95 (APO-1/Fas)-mediated apoptosis in colon epithelial cells: A possible role in ulcerative colitis
25. Apoptosis and the expression of Fas and Fas ligand (FasL) antigen in rejection and reinfection in liver allograft specimens
26. Involvement of CD95/Apo1/Fas in cell death after myocardial ischemia
27. Pentoxifylline: A review of its pharmocodynamic and pharmacokinetic properties, and its therapeutic efficacy
28. The regulation of tumor necrosis factor-alpha production in murine mast cells: Pentoxifylline or dexamethasone inhibits IgE-dependent production of TNF-alpha by distinct mechanisms
29. Pentoxifylline selectivity inhibits tumor necrosis factor synthesis in the arterial wall
30. Calpain mediates ischemic injury of the liver through modulation of apoptosis and necrosis
31. A new and simple technique of total hepatic ischemia in the mouse
32. Markers of allograft viability in the rat. Relationship between transplantation viability and liver function in the isolated perfused rat liver
33. Apoptosis induced by tumor necrosis factor-alpha in rat hepatocyte cell lines expressing hepatitis B virus
34. Tumor necrosis factor-induced apoptosis precedes liver failure in experimental murine shock models
35. Tumor necrosis factor-induced apoptosis during the poisoning of mice with hepatotoxins
36. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade
37. Cytochrome c deficiency causes embryonic lethality and attenuates stress-induced apoptosis
38. Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis
39. Apoptotic pathways: Paper wraps stone blunt scissors
40. Mechanisms of ischemic injury are different in the steatotic and normal rat liver
41. Role of tumor necrosis factor-alpha in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat
42. Bcl-2 overexpression in transgenic mice protects against ischemia & reperfusion injury of the liver
43. Mechanism of cell death during warm hepatic ischemia-reperfusion in rats: Apoptosis or necrosis?
44. Tumor necrosis factor receptor superfamily members and their ligands
45. Inhibition of human neutrophil binding to hydrogen peroxide-treated endothelial cells by cAMP and hydroxyl radical scavengers
46. Pentoxifylline. A hydroxyl radical scavenger
47. Initiation of liver growth by tumor necrosis factor: Deficient liver regeneration in mice lacking type I tumor necrosis factor receptor
48. Glutathione modulates rat and mouse hepatocyte sensitivity to tumor necrosis factor alpha toxicity
49. Possible requirement of internalization in the mechanism of in vitro cytotoxicity in tumor necrosis serum
50. In situ determination by surface chemiluminescence of temporal relationships between evolving warm ischemia-reperfusion injury in rat liver and phagocyte activation and recruitment
51. The role of oxiant injury in tumor cell sensitivity to recombinant human tumor necrosis factor in vivo
52. Tumor necrosis factor alpha prevents tumor necrosis factor receptor-mediated mouse hepatocyte apoptosis, but not Fas-mediated apoptosis: Role of nuclear factor-kappaB
53. PEGylated recombinant human soluble tumour necrosis factor receptor type I (r-Hu-sTNF-R1): Novel high affinity TNF receptor designed for chronic inflammatory diseases
54. The use of synthetic analogues of Arg-Gly-Asp (RGD) and soluble receptor of tumor necrosis factor to prevent acute and chronic experimental liver injury
55. Thalidomide inhibits tumor necrosis factor alpha, decreases nitric oxide synthesis, and ameliorates the hyperdynamic circulatory syndrome in portal-hypertensive rats